Inventor · disambiguated record
Min Jiang
Also filed as: JIANG MIN
22 granted patents·10 pending applications·166 citations·filing 1996–2025
95Inventor score
Files withHOFFMANN LA ROCHE13VERTEX PHARMA6EVE ENERGY STORAGE CO LTD2UNIV SASKATCHEWAN2BARTELS DOUGLAS J1
Top patents by PatentIndex Score
32 records- 0196US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0295US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 0394US11945167B1Three-degree-of-freedom convenient mobile powder recovery device and recovery methodUNIV BEIJING SCIENCE & TECHNOLOGY·Filed 2023·Granted Apr 2, 2024·3 cites·10 claims
- 0494US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 0594US9458153B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Oct 4, 2016·23 cites·20 claims
- 0694US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 0792US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 0891US10093671B22-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Oct 9, 2018·14 cites·17 claims
- 0991US9845322B2Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Dec 19, 2017·7 cites·46 claims
- 1088US9637485B26,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted May 2, 2017·9 cites·25 claims
- 1185US10053461B2Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 21, 2018·3 cites·21 claims
- 1283US11708344B2Flavone derivatives for the treatment and prophylaxis of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Jul 25, 2023·3 cites·29 claims
- 1383US9949966B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Apr 24, 2018·4 cites·21 claims
- 1481US11104674B2Tetrahydropyridopyrimidines for the treatment of HBV infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 31, 2021·2 cites·33 claims
- 1574US2025391940A1Energy storage containerEVE ENERGY STORAGE CO LTD·Filed 2024·Application pending·0 cites
- 1668US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 1767US2025387652A1Energy storage containerEVE ENERGY STORAGE CO LTD·Filed 2025·Application pending·0 cites
- 1855US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 1953US11225482B2Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Jan 18, 2022·0 cites·17 claims
- 2050US5863543ACamp factor of streptococcus uberisUNIV SASKATCHEWAN·Filed 1996·Granted Jan 26, 1999·15 cites·6 claims
- 2147US9079892B2Method for preparing rivaroxaban intermediateCHINA NAT MEDICINES GUORUI PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 14, 2015·0 cites·11 claims
- 2246US11447489B2Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Sep 20, 2022·0 cites·16 claims
- 2346US2021387996A1Tricyclic compounds for the treatment and prophylaxis of hepatitis b virus diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2446US2020368262A1Use of Timosaponin Enzymatically Transformed Product in Preparation of Drugs for Inhibiting Skin Superficial FungiUNIV SHANGHAI TRADITIONAL CHINESE MEDICINE·Filed 2020·Application pending·0 cites
- 2545US2024024465A1Allergen preparationGLALLERGEN CO LTD·Filed 2021·Application pending·0 cites
- 2643US2017113266A1Sector-shaped section of continuous casting machine for heavy reduction of solidified terminal of continuously cast slab and heavy reduction method thereofUNIV BEIJING SCIENCE & TECH·Filed 2017·Application pending·0 cites
- 2740US2014242673A1Chemically defined culture medium for fermentation to produce succinic acid and application thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2012·Application pending·0 cites
- 2837US9562242B2Method for reusing water in fermented butanedioic acid separation processJIANG MIN·Filed 2012·Granted Feb 7, 2017·0 cites·2 claims
- 2934US2015266878A1Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancerHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 3033US2013157258A1Hcv ns5b protease mutantsBARTELS DOUGLAS J·Filed 2011·Application pending·0 cites
- 3131US9458106B2Phenyl-pyridine/pyrazine amides for the treatment of cancerHOFFMANN LA ROCHE·Filed 2015·Granted Oct 4, 2016·0 cites·13 claims
- 3227US6908619B1Camp factor of streptococcus uberisUNIV SASKATCHEWAN·Filed 1999·Granted Jun 21, 2005·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Min Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →